Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-30FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc. The action u…
-
FDA approval · 2016-11-30FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for guanfacine, enabling continued marketing of a generic product. This act…
-
FDA approval · 2016-11-30FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Par Health USA, LLC)
FDA approved an Original Application for dexmethylphenidate hydrochloride, a generic ADHD medication, manufactured by Par Health USA, LLC.
-
FDA approval · 2016-11-07FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for methylphenidate hydrochloride from Rising Pharma Holdings, Inc., a generic stimulant indicated for…
-
FDA approval · 2016-10-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a methylphenidate hydrochloride generic product manufactured by SpecGx LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-28FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a generic product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetam…
-
FDA approval · 2016-10-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for SpecGx LLC to market methylphenidate hydrochloride extended-release as a generic ADHD treatment.
-
FDA approval · 2016-10-28FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate by SpecGx LLC under an ANDA. This action confirms the approval of a ge…
-
FDA approval · 2016-10-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methylphenidate hydrochloride extended-release from SpecGx LLC.
-
FDA approval · 2016-10-25FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application from SpecGx LLC for dextroamphetamine sulfate extended-release, clearing a generic extended-rele…
-
FDA approval · 2016-10-14FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for VYVANSE (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-09-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for four amphetamine salt products (dextroamphetamine saccharate, amphetamine aspartate, dextro…
-
FDA approval · 2016-08-26FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approves Cranbury Pharmaceuticals' dexmethylphenidate hydrochloride as an original-application generic product (for attention-deficit/hy…
-
FDA approval · 2016-08-22FDA Approved: GUANFACINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for guanfacine hydrochloride from Aurobindo Pharma Limited, authorizing changes to the approved …
-
FDA approval · 2016-08-19FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the methylphenidate transdermal system submitted by PADAGIS US LLC.
-
FDA approval · 2016-07-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's generic methylphenidate hydrochloride product under an Original Application. It is…
-
FDA approval · 2016-07-07FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc., resulting in an approved mod…
-
FDA approval · 2016-06-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for methylphenidate hydrochloride (LA) from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2016-05-27FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) submitted by Novartis Pharmaceuticals Corporation to mod…
-
FDA approval · 2016-05-27FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc.
-
FDA approval · 2016-05-13FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) from Sandoz Inc. The action updates the product's app…
-
FDA approval · 2016-05-13FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. The approval c…
-
FDA approval · 2016-04-15FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc. unde…
-
FDA approval · 2016-03-16FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin's dextroamphetamine sulfate as an original ANDA, enabling a generic version of the stimulant for ADHD and narcolepsy.
-
FDA approval · 2016-03-05FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' supplemental application for methylphenidate hydrochloride long-acting (LA), a generic ADHD medicatio…